Friday, August 28, 2026 Never miss a recall or a rule change Go Pro · $20/mo →
Inside MedSpa
FDA Recall & Compliance Alerts for Medspa Owners
Business & M&AWall Street Sees 77% Upside in Evolus StocktodayDevices & TechClassys Global Device Sales to Surpass 50,000 Units in 20262 days agoBusiness & M&AInMode Consolidates Amid Potential Trading ShifttodayDevices & TechInMode Consolidates Between Support and Resistance Levels2 days agoBusiness & M&ASisram Medical Posts Solid H1 2026 ResultstodayBusiness & M&ASisram Medical H1 2026: APAC Growth Offsets Margin Pressure2 days agoDevices & TechMedical Aesthetics by Lacey Adds Tixel 2 to MenutodayBusiness & M&AEvolus Q2 Revenue Beats Forecast, Raises 2026 Outlook2 days agoDevices & TechCytrellis Launches Ellacor in AustraliayesterdayDevices & TechNew Tool for Sagging Skin Gains Practitioner TractionyesterdayComplianceWarning: Unapproved Obesity Shot Sold at U.S. Medical SpasyesterdayDevices & TechAlma Lasers Unveils Harmony Platformyesterday
1 free article left this week. A free account gets you 4 a week.Go Pro →
Devices & Tech

Cynosure Launches XERF Monopolar RF Platform in Europe — Next-Gen Skin Tightening Competes with Thermage

Cynosure's new monopolar RF system enters the European market as non-invasive skin-tightening demand accelerates.

Image: Inside MedSpa
1-YEAR MOVE
+3% −14%
INMD ▲1.0%
1-year price move by ticker
TickerCompany1-year change
INMDInMode Ltd.+1.0%

Cynosure (Lutronic) has launched XERF, a next-generation monopolar radiofrequency platform, across European markets. Monopolar RF—which delivers energy deeper into dermis and subcutis than fractional or bipolar modalities—targets skin laxity and collagen remodeling, competing directly with Thermage and Inmode's Morpheus8 (though the latter combines RF with microneedling).

XERF's positioning emphasizes non-invasive body and face contouring without downtime, a clinical niche that has grown as demand for alternatives to surgical lift accelerates. Monopolar RF's mechanism—uniform heat distribution across larger treatment areas—suits practices seeking high-volume, lower-touch procedures with predictable outcomes.

Cynosure's monopolar RF platform targets non-invasive skin tightening as demand for body contouring accelerates.

The European launch reflects Cynosure's strategy to diversify beyond laser platforms and compete in the energy-device consolidation trend. Practices evaluating RF platforms should assess treatment depth, energy delivery consistency, and consumable costs against established competitors.

Source: original report ↗

Frequently asked questions

What is the difference between monopolar RF and bipolar RF for skin tightening?

Monopolar RF delivers energy deeper into the dermis and subcutis than bipolar or fractional RF modalities, making it more effective for significant skin laxity and collagen remodeling. Monopolar systems like XERF use uniform heat distribution across larger treatment areas, while bipolar RF operates more superficially and typically requires more passes to achieve results.

How does Cynosure's XERF compare to Thermage?

Both XERF and Thermage are monopolar RF platforms designed for non-invasive skin tightening without downtime. XERF is Cynosure's newest entry into the European market and emphasizes consistent energy delivery and body/face contouring, positioning itself as a direct competitor to Thermage's established market presence.

Is monopolar RF better than Morpheus8 for skin tightening?

Morpheus8 combines RF with microneedling, offering a hybrid approach, while monopolar RF platforms like XERF focus purely on radiofrequency energy for deeper collagen remodeling. The choice depends on your patient goals: monopolar RF suits those wanting non-invasive tightening alone, while Morpheus8 may appeal to patients seeking combined RF and microneedling benefits.

What should medspa owners consider when choosing an RF platform?

Evaluate treatment depth capability, consistency of energy delivery across sessions, consumable costs, and how the system fits your high-volume procedure model. Compare these factors against established competitors like Thermage to ensure the platform meets your practice's clinical and financial requirements.

Does monopolar RF skin tightening require downtime?

No, monopolar RF platforms like XERF are designed as non-invasive procedures with no downtime, making them attractive alternatives to surgical lifts. Patients can return to normal activities immediately after treatment.

Why is Cynosure launching XERF in Europe now?

Cynosure is expanding beyond its core laser platform business to compete in the growing non-invasive skin-tightening market as demand for alternatives to surgical procedures accelerates. The European launch reflects the company's broader strategy to diversify into energy-device consolidation and capture market share in the monopolar RF segment.

Free alerts

Free: recall & rule-change alerts for your practice.

Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.

Free · weekly · unsubscribe anytime. Privacy.

Stay three moves ahead of every practice in your market.

Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.

Get the edge · $20/mo

Join the owners who run ahead of the industry. Cancel anytime, one click.

Share

https://insidemedspa.com/article/cynosure-xerf-monopolar-rf-europe-launch/

Discussion

    Leave a comment

    Comments are reviewed before they appear.
    Inside MedSpa Pro

    By the time it's news, it's too late.

    The rebate cut, the scope-of-practice bill, the competitor opening down the street — it hits your business before the trade press ever covers it. Pro gets you there first: what happened, why it touches your margins, and exactly what to do — at 6 AM, in two minutes.

    Go Pro · $20/mo Never miss a recall or a rule change. Cancel anytime.
    The twice-a-week intelligence brief Go Pro · $20/mo